Free Trial

Catheter Precision (VTAK) 10K Form and Latest SEC Filings 2026

Catheter Precision logo
$0.93 -0.01 (-1.49%)
Closing price 05/5/2026 04:10 PM Eastern
Extended Trading
$0.94 +0.01 (+1.30%)
As of 05/5/2026 07:42 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Latest Catheter Precision SEC Filings & Recent Activity

Catheter Precision (NYSEAMERICAN:VTAK) has submitted 397+ documents to the U.S. Securities and Exchange Commission (SEC) since 2018. For investors, these filings are the primary source of verified financial data — covering everything from annual revenue and debt levels in the 10-K, to material business events in 8-K current reports, to insider buying and selling activity in Form 4 disclosures. The most recent filing was a Form 10-K/A submitted on April 30, 2026.

8-K
Catheter Precision Files Current Report on Apr. 23, 2026

An 8-K is filed when a material corporate event occurs, such as an acquisition, leadership change, or financial update.

View filing

10-K
Catheter Precision Files Annual Report on Apr. 30, 2026

The 10-K contains Catheter Precision's audited financial statements, revenue, earnings, and risk factors for the prior fiscal year.

View earnings history

Catheter Precision SEC Filing History

Browse Catheter Precision's complete SEC filing history using the filters below. Filter by form type - 10-K, 10-Q, 8-K, Form 4, and more - or set a custom date range to find a filing.

DateFilerForm TypeView
04/30/2026 3:19 PM
Catheter Precision (1716621) Filer
Form 10-K/A
04/23/2026 3:17 PM
Catheter Precision (1716621) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/15/2026 3:16 PM
Catheter Precision (1716621) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/31/2026 3:55 PM
Catheter Precision (1716621) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/31/2026 10:07 AM
Catheter Precision (1716621) Filer
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/23/2026 3:15 PM
Catheter Precision (1716621) Filer
Form DEF 14A
03/23/2026 3:16 PM
Catheter Precision (1716621) Filer
Form DEFA14A
03/13/2026 4:07 PM
Catheter Precision (1716621) Filer
Form PRE 14A
03/09/2026 4:06 PM
Catheter Precision (1716621) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/11/2026 4:04 PM
Castaldo Gregory (2038245) Filed by
Catheter Precision (1716621) Subject
Form SCHEDULE 13G
02/11/2026 2:28 PM
Catheter Precision (1716621) Subject
Reda Joseph (1952100) Filed by
Form SCHEDULE 13G
02/06/2026 4:25 PM
Catheter Precision (1716621) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/08/2025 3:45 PM
Catheter Precision (1716621) Issuer
JENKINS DAVID A (1279803) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
12/08/2025 3:54 PM
Caruso James Joseph (1397215) Reporting
Catheter Precision (1716621) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2025 3:15 PM
Catheter Precision (1716621) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2025 4:20 PM
Catheter Precision (1716621) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/15/2025 3:15 PM
Catheter Precision (1716621) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/15/2025 7:46 AM
Catheter Precision (1716621) Filer
Form DEF 14A
09/04/2025 3:24 PM
Catheter Precision (1716621) Filer
Form DEFA14A
09/04/2025 3:25 PM
Catheter Precision (1716621) Filer
Form PRE 14A
08/18/2025 4:14 PM
Catheter Precision (1716621) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/15/2025 3:59 PM
Catheter Precision (1716621) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2025 8:22 PM
ARMISTICE CAPITAL, LLC (1601086) Filed by
Catheter Precision (1716621) Subject
Form SCHEDULE 13G/A
08/14/2025 3:33 PM
Catheter Precision (1716621) Issuer
COLOMBATTO MARTIN J (1208236) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2025 3:33 PM
Caruso James Joseph (1397215) Reporting
Catheter Precision (1716621) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2025 3:34 PM
Arno Andrew (1472122) Reporting
Catheter Precision (1716621) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2025 3:15 PM
Catheter Precision (1716621) Filer
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
06/13/2025 5:23 AM
Catheter Precision (1716621) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/13/2025 5:24 AM
Catheter Precision (1716621) Filer
Form 424B5
06/09/2025 6:51 AM
Catheter Precision (1716621) Filer
Form DEFA14A
06/09/2025 6:53 AM
Catheter Precision (1716621) Filer
Form DEFA14A
06/09/2025 6:45 AM
Catheter Precision (1716621) Filer
Form ARS
06/09/2025 6:51 AM
Catheter Precision (1716621) Filer
Form DEF 14A
06/09/2025 6:35 AM
Catheter Precision (1716621) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/09/2025 6:35 AM
Catheter Precision (1716621) Filer
Form DEFA14A
06/06/2025 3:16 PM
Catheter Precision (1716621) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/01/2025 11:15 PM
Catheter Precision (1716621) Filer
Form EFFECT
05/30/2025 4:08 PM
Catheter Precision (1716621) Filer
Form 424B3
05/30/2025 3:15 PM
Catheter Precision (1716621) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/30/2025 3:17 PM
Catheter Precision (1716621) Filer
Form PRE 14A
05/21/2025 3:35 PM
Catheter Precision (1716621) Filer
Form S-3
Registration statement under Securities Act of 1933  
05/15/2025 2:21 PM
ARMISTICE CAPITAL, LLC (1601086) Filed by
Catheter Precision (1716621) Subject
Form SCHEDULE 13G/A
05/14/2025 3:16 PM
Catheter Precision (1716621) Filer
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
(Data available from 1/1/2016 forward)

Catheter Precision SEC Filings - Frequently Asked Questions

Catheter Precision (VTAK) has submitted 397+ filings to the SEC since 2018. You can browse the complete history or filter by form type using the tools above.

Catheter Precision's fiscal year ends on December 31. The company typically files its 10-K annual report by the end of February, covering the prior fiscal year's financial results.

The most recent filing was a Form 10-K/A submitted on April 30, 2026. View the full filing using the link above.

SEC Filing Types: 10-K, 10-Q, 8-K and More

SEC filings are legally required disclosures that public companies submit to the U.S. Securities and Exchange Commission. Unlike press releases or earnings call transcripts, these documents are filed under legal obligation — meaning the financial data they contain is audited, standardized, and subject to penalties if materially false. For investors, that makes SEC filings the most reliable primary source available for evaluating a company's true financial position.

Yes. All SEC filings are publicly available through the SEC's EDGAR database and on financial research platforms like MarketBeat. Companies are required by law to make these disclosures accessible to all investors — meaning retail investors have access to the same source documents as institutional analysts.

A 10-K is an annual report containing audited financial statements and a full review of the company's business — it is the most comprehensive filing a company makes each year. A 10-Q is a shorter, unaudited quarterly update filed three times per year between annual reports. Investors typically use the 10-K for deep fundamental analysis and the 10-Q to track whether the company is on pace with its guidance mid-year.

The most important filing for fundamental investors. Filed once per year, the 10-K contains audited financial statements, revenue and earnings trends, debt obligations, risk factors, and management's own assessment of the business. Reading the risk factors section and comparing year-over-year financials can reveal issues that don't show up in analyst summaries.

An unaudited financial update filed three times per year (the 10-K covers Q4). Investors use 10-Qs to track whether guidance is on pace, monitor changes in cash flow or inventory, and catch any mid-year shifts in business conditions before they become headline news.

Filed within four business days of a material event — earnings releases, merger announcements, executive departures, or major asset sales. Because 8-Ks are filed before media coverage catches up, they are often the fastest way to get unfiltered information directly from the company on market-moving events.

Filed within two business days whenever an executive or director buys or sells company stock. Insider purchases — especially large or clustered buys — are often interpreted as a signal of management confidence. Insider selling is more ambiguous but worth monitoring for patterns, particularly around lock-up expirations or ahead of major announcements.


Related Companies and Tools


This page (NYSEAMERICAN:VTAK) was last updated on 5/6/2026 by MarketBeat.com Staff.
From Our Partners